SCHEMBL23920877

SCHEMBL23920877

CCCSc1nc2c(=O)n3cc(-c4ccc(OC)cc4)[nH]c3nc2n1CCO

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 6/20 0.49
ADORA1 P30542 3/20 0.41
APLNR P35414 2/20 0.41
ADORA2A P29274 3/20 0.38
ADORA2B P29275 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
MAPT P10636 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
MAOB P27338 1/20 0.35
KDM1A O60341 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TSHR P16473 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23921020 0.89 ADORA3 (0.47) ADORA3ADORA1ADORA2AADORA2BKDM4E
SCHEMBL23920870 0.89 ADORA3 (0.52) ADORA3ADORA1APLNRALDH1A1MEN1
SCHEMBL23920998 0.83 ADORA3 (0.48) ADORA3ADORA1KDM4EALDH1A1HPGD
SCHEMBL23921154 0.83 ADORA3 (0.49) ADORA3ADORA1ADORA2AADORA2BKDM4E
SCHEMBL23920978 0.82 ADORA3 (0.52) ADORA3ADORA1KDM4EALDH1A1HPGD
SCHEMBL23921155 0.81 ADORA3 (0.46) ADORA3ADORA1ALDH1A1HSD17B10MEN1
SCHEMBL23921143 0.80 ADORA3 (0.46) ADORA3ADORA1ALDH1A1HPGDMAPT
SCHEMBL23920859 0.78 ADORA3 (0.46) ADORA3ADORA1
SCHEMBL23921233 0.78 ADORA3 (0.51) ADORA3ADORA1KDM4EMAPTMEN1
SCHEMBL21396510 0.77 ADORA3 (0.46) ADORA3ADORA1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2023-08-03 US disclosed
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PRKAG3 ADORA3 425/4885ADORA1 857/4885APLNR 1829/4885
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A ADORA3 449/4885ADORA1 828/4885APLNR 1603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.